成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 6515-58-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6515-58-8
Chemical Structure| 6515-58-8
Structure of 6515-58-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 6515-58-8 ]

Related Doc. of [ 6515-58-8 ]

Alternatived Products of [ 6515-58-8 ]
Product Citations

Product Citations

Nkomba, Gaofenngwe ; Terre'Blanche, Gisella ; van Rensburg, Helena Dorathea Janse , et al. DOI: PubMed ID:

Abstract: Due to the implication of adenosine in seizure suppression, adenosine-based therapies such as adenosine receptor (AR) agonists have been investigated. This study aimed at investigating thieno[2,3 b]pyridine derivatives as non-nucleoside A1 agonists that could be used in pharmaco-resistant epilepsy (PRE). Compound 7c (thieno[2,3-b]pyridine derivative), displayed good binding a nity to the rA1 AR (Ki = 61.9 nM). This could be a breakthrough for further investigation of this heterocyclic scaffold as potential ligand. In silico evaluation of this compound raised bioavailability concerns but performed well on drug likeness tests. The effect of intramolecular cyclisation that occurs during synthesis of thieno[2,3 b]pyridines from the lead compounds, amino-3,5-dicyanopyridine derivatives ( 6a-s) in relation to AR binding was also evaluated. A signi cant loss of activity against rA1/rA2A ARs with cyclisation was revealed. Amino-3,5-dicyanopyridines exhibited greater a nity towards rA1 ARs (Ki

Keywords: Amino-3,5-dicyanopyryridines ; Thieno[2,3-b]pyridines ; Intramolecular cyclisation ; Adenosine A1/A2A receptors ; Epilepsy

Purchased from AmBeed: ; ;

Product Details of [ 6515-58-8 ]

CAS No. :6515-58-8 MDL No. :MFCD00045839
Formula : C8H7BrO2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :-
M.W : 215.04 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 6515-58-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.24
TPSA : 37.3 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 2.24
Log Po/w (WLOGP) : 2.13
Log Po/w (MLOGP) : 2.4
Log Po/w (SILICOS-IT) : 2.21
Consensus Log Po/w : 2.12

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.86
Solubility : 0.3 mg/ml ; 0.00139 mol/l
Class : Soluble
Log S (Ali) : -2.66
Solubility : 0.472 mg/ml ; 0.00219 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.04
Solubility : 0.198 mg/ml ; 0.000923 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.58

Safety of [ 6515-58-8 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P264-P270-P280-P301+P312+P330-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P362+P364-P405-P501 UN#:3261
Hazard Statements:H302+H312-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 6515-58-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6515-58-8 ]

[ 6515-58-8 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 6515-58-8 ]
  • [ 170853-04-0 ]
  • 2
  • [ 6515-58-8 ]
  • [ 59702-07-7 ]
  • [ 571187-05-8 ]
YieldReaction ConditionsOperation in experiment
With potassium carbonate; In ethanol; at 20℃; for 17h; A mixture of 3-bromomethylbenzoic acid (4.30 g, 20 mmol), <strong>[59702-07-7]1-<strong>[59702-07-7]methylpiperazin-2-one</strong></strong> (2.3 g, 20 mmol),38 and powdered potassiumcarbonate (2.76 g, 20 mmol) in ethanol (50 mL) was stirredfor 17 h at room temperature. The solvent was evaporated off underreduced pressure to give a residue which was treated with HCl(10 mL of 2 M) and extracted with EtOAc. The combined extractswere washed with water, dried and the solvent was evaporatedoff under reduced pressure to give 8, which was recrystallised fromEtOAc/hexane to give a cream crystalline solid, mp 161?166 C; 1HNMR (DMSO-d6) d 2.63 (t, J = 5.5 Hz, 2H), 2.80 (s, 3H), 2.96 (s, 2H),3.26 (t, J = 5.5, 2H), 3.61 (s, 2H), 7.46 (d, J = 8.0 Hz, 2H), 7.90 (d,J = 8.0 Hz, 2H), 12.9 (br s, 1H).
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 6515-58-8 ]

Aryls

Chemical Structure| 2417-73-4

[ 2417-73-4 ]

Methyl 2-bromomethylbenzoate

Similarity: 0.89

Chemical Structure| 1129-28-8

[ 1129-28-8 ]

Methyl 3-(bromomethyl)benzoate

Similarity: 0.89

Chemical Structure| 2417-72-3

[ 2417-72-3 ]

Methyl 4-(bromomethyl)benzoate

Similarity: 0.89

Chemical Structure| 52062-92-7

[ 52062-92-7 ]

4-(2-Bromoethyl)benzoic acid

Similarity: 0.86

Chemical Structure| 7697-28-1

[ 7697-28-1 ]

4-Bromo-3-methylbenzoic acid

Similarity: 0.85

Bromides

Chemical Structure| 2417-73-4

[ 2417-73-4 ]

Methyl 2-bromomethylbenzoate

Similarity: 0.89

Chemical Structure| 1129-28-8

[ 1129-28-8 ]

Methyl 3-(bromomethyl)benzoate

Similarity: 0.89

Chemical Structure| 2417-72-3

[ 2417-72-3 ]

Methyl 4-(bromomethyl)benzoate

Similarity: 0.89

Chemical Structure| 52062-92-7

[ 52062-92-7 ]

4-(2-Bromoethyl)benzoic acid

Similarity: 0.86

Chemical Structure| 7697-28-1

[ 7697-28-1 ]

4-Bromo-3-methylbenzoic acid

Similarity: 0.85

Benzyl bromides

Chemical Structure| 2417-73-4

[ 2417-73-4 ]

Methyl 2-bromomethylbenzoate

Similarity: 0.89

Chemical Structure| 1129-28-8

[ 1129-28-8 ]

Methyl 3-(bromomethyl)benzoate

Similarity: 0.89

Chemical Structure| 2417-72-3

[ 2417-72-3 ]

Methyl 4-(bromomethyl)benzoate

Similarity: 0.89

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.80

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.80

Carboxylic Acids

Chemical Structure| 52062-92-7

[ 52062-92-7 ]

4-(2-Bromoethyl)benzoic acid

Similarity: 0.86

Chemical Structure| 7697-28-1

[ 7697-28-1 ]

4-Bromo-3-methylbenzoic acid

Similarity: 0.85

Chemical Structure| 790230-04-5

[ 790230-04-5 ]

4-Bromo-3-(hydroxymethyl)benzoic acid

Similarity: 0.83

Chemical Structure| 586-76-5

[ 586-76-5 ]

4-Bromobenzoic acid

Similarity: 0.82

Chemical Structure| 53663-39-1

[ 53663-39-1 ]

2-Bromo-3-methylbenzoic acid

Similarity: 0.81

; ;